AbbVie Becomes Official Pharmaceutical Partner of Major League Baseball
AbbVie has unveiled a landmark multi-year partnership with Major League Baseball (MLB), officially naming the company as the league’s “Official Pharmaceutical Partner” beginning with the 2026 season. This collaboration represents a major milestone for AbbVie, marking the first time the company has entered into a comprehensive, league-wide partnership of this scale within professional sports. More significantly, the agreement serves as a powerful platform to expand AbbVie’s cancer awareness initiative, Striking Out Cancer, from a localized program into a nationwide campaign reaching millions of baseball fans across the United States and beyond.
The origins of Striking Out Cancer trace back to the 2025 MLB season, when AbbVie partnered with the Chicago Cubs to introduce the initiative in its hometown of Chicago. What began as a city-focused effort to raise awareness around cancer and support research funding has now evolved into a league-wide movement. With this expansion, the program will be embedded into every MLB game throughout the season, transforming routine in-game statistics into meaningful contributions toward cancer research and advocacy.
At the heart of the initiative lies a simple yet impactful mechanism: for every strikeout recorded during the MLB season, AbbVie will donate $20, up to a maximum of $1 million annually. This symbolic contribution is grounded in a sobering global health statistic—approximately 20% of the world’s population will be diagnosed with cancer before the age of 75, according to data from the World Health Organization. By tying each strikeout to a donation, the campaign not only raises funds but also fosters awareness, connecting fans to the broader fight against cancer in a tangible and memorable way.
With MLB games collectively generating an average of 40,000 strikeouts per season, the initiative presents consistent, season-long opportunities to drive engagement and amplify its impact. Beyond the baseline contributions, AbbVie has also committed to increasing donations during marquee league events and special moments. These include heightened contributions during high-profile games as well as additional donations in the rare instances of a perfect game or no-hitter—events that capture national attention and bring heightened visibility to the campaign’s mission.
The funds raised through Striking Out Cancer will directly benefit Stand Up To Cancer (SU2C), a prominent organization dedicated to accelerating groundbreaking cancer research and fostering collaboration across the scientific community. SU2C has long been recognized for its innovative funding model, which emphasizes team science and rapid translation of research discoveries into clinical applications. Through this partnership, AbbVie and MLB aim to channel the energy of America’s pastime into meaningful advancements in oncology research and patient care.
AbbVie’s leadership emphasized the broader societal importance of the initiative, highlighting the role of partnerships in bridging the gap between scientific innovation and public awareness. According to Tracie Haas, Senior Vice President of Corporate Affairs at AbbVie, cancer continues to impact millions of families worldwide, underscoring the need for initiatives that meet people where they are. By integrating Striking Out Cancer into the fabric of MLB games, the company seeks to spark meaningful conversations around cancer awareness, prevention, and treatment, while reinforcing its long-standing commitment to improving patient outcomes.
The campaign’s reach will extend far beyond the ballpark. Throughout the season, Striking Out Cancer will be prominently featured across MLB’s extensive media ecosystem, including broadcasts on MLB Network, as well as the league’s digital platforms and social media channels. This multi-channel approach ensures that the campaign resonates with a broad and diverse audience, leveraging MLB’s massive fan base to amplify its message.
In addition to its presence during regular-season games, the initiative will be showcased during some of MLB’s most high-profile events. These include the All-Star Game, MLB at Field of Dreams, and the MLB Wild Card Series, which will officially be presented by AbbVie beginning in the 2026 postseason. By aligning with these marquee moments, the campaign gains heightened visibility and reinforces its connection to the sport’s most celebrated traditions.
The partnership also underscores the growing role of sports as a platform for social impact and advocacy. MLB, through its social responsibility initiatives, has increasingly sought to leverage its influence to address pressing societal challenges. April Brown, MLB’s Senior Vice President of Social Responsibility, noted that the collaboration with AbbVie exemplifies the transformative potential of sports-driven advocacy. By turning each strikeout into an opportunity for impact, the initiative redefines a routine statistic as a symbol of hope and progress in the fight against cancer.
From a broader perspective, the collaboration represents a unique intersection of science, sport, and storytelling. AbbVie, a global leader in oncology research and development, brings its scientific expertise and commitment to innovation, while MLB contributes its unparalleled platform and cultural significance. Together, they create a compelling narrative that resonates with fans, patients, and the wider community.
For Stand Up To Cancer, the partnership provides a valuable boost to its mission of accelerating cancer research and delivering new treatments to patients. Rusty Robertson, co-founder of SU2C, expressed deep appreciation for AbbVie’s support, emphasizing the importance of collaborative efforts in driving progress against cancer. He also acknowledged MLB’s longstanding commitment to the cause, noting that the league has been a founding donor and a consistent supporter of cancer research initiatives.
The launch of Striking Out Cancer for the 2026 season is set to coincide with MLB’s Opening Day, marking the beginning of what promises to be a highly visible and impactful campaign. From the first pitch of the season through the culmination of the postseason, the initiative will serve as a constant reminder of the ongoing fight against cancer and the collective efforts required to advance research and improve patient outcomes.
Ultimately, this partnership between AbbVie and Major League Baseball represents more than just a sponsorship agreement—it is a strategic and purpose-driven collaboration aimed at harnessing the power of sport to address one of the most significant health challenges of our time. By transforming every strikeout into a contribution toward cancer research, Striking Out Cancer embodies a simple yet powerful idea: that small actions, when multiplied across a season and a nation, can lead to meaningful change.
As the 2026 MLB season unfolds, fans will not only be cheering for their favorite teams but also participating, in their own way, in a broader mission to combat cancer. Through this innovative partnership, AbbVie and MLB are demonstrating how the worlds of healthcare and sports can come together to inspire hope, drive awareness, and ultimately make a lasting difference in the lives of patients and families around the world.
Source Link:https://news.abbvie.com/
